$BETA Balance Sheet | Understand Stock

$BETA

$19.82 +$0.02 (0.1%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025
Assets
Current assets:
Cash and cash equivalents
Accounts receivable
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Prepaid expenses and other non-current assets
Other assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
Accrued expenses
Payroll liabilities
Deferred revenue
Operating lease liabilities
Notes payable
Accrued expenses and other current liabilities
Other current liabilities
Total current liabilities
Deferred revenue, non-current
Operating lease liabilities, non-current
Notes payable, non-current
Other liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.0001 par value Authorized - 50,000,000 shares Issued and outstanding - 0 shares in 2025 and 2024
Convertible Series A preferred stock
Convertible Preferred Stock (Series A, B, C and C-1)
Series A
Series B
Series C
Series C-1
Total convertible Preferred Stock (Series A, B, C and C-1)
Total preferred stock, $0.0001 par value Authorized - 50,000,000 shares Issued and outstanding - 0 shares in 2025 and 2024
Common stock
Common stock, excluding super voting
Common stock, super voting
Class A Common Stock
Class B Common Stock
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments